Binghamton, New York • Velocity Clinical Research
Phone: (607) 800-5777
Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are common viruses that can cause respiratory infections, especially in infants, children, seniors and immunocompromised people. Velocity is conducting a clinical trial for a combined investigational mRNA vaccine for RSV and hMPV for adults.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy